117 related articles for article (PubMed ID: 6299620)
1. Opiate modulation of the pituitary-adrenal axis: effects of stress and circadian rhythm.
Grossman A; Gaillard RC; McCartney P; Rees LH; Besser GM
Clin Endocrinol (Oxf); 1982 Sep; 17(3):279-86. PubMed ID: 6299620
[TBL] [Abstract][Full Text] [Related]
2. An analogue of met-enkephalin attenuates the pituitary-adrenal response to ovine corticotrophin releasing factor.
Grossman A; Delitala G; Mannelli M; Al-Damluji S; Coy DH; Besser GM
Clin Endocrinol (Oxf); 1986 Oct; 25(4):421-6. PubMed ID: 3040301
[TBL] [Abstract][Full Text] [Related]
3. Met-enkephalin and the enkephalin analogue FK-33824 centrally inhibit adrenocorticotrophic hormone secretion in sheep.
Wang XM; Tresham JJ; Scoggins BA; Coghlan JP
Clin Exp Pharmacol Physiol; 1988 Nov; 15(11):865-73. PubMed ID: 2852564
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
Inder WJ; Ellis MJ; Evans MJ; Donald RA
Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
[TBL] [Abstract][Full Text] [Related]
5. The met-enkephalin analog FK 33-824 and naloxone do not directly influence cortisol secretion by cultured human adrenocortical cells.
Lamberts SW; Bons EG; Del Pozo E
Life Sci; 1983 Feb; 32(7):755-8. PubMed ID: 6402629
[TBL] [Abstract][Full Text] [Related]
6. Effects of a [Met]-enkephalin analogue ( [D-Ala2,N-Me-Phe4,Met-(O)5-ol]-enkephalin) on canine pituitary function.
Meij BP; Rijnberk A; Mol JA
J Endocrinol; 1990 Nov; 127(2):265-71. PubMed ID: 2174454
[TBL] [Abstract][Full Text] [Related]
7. Exogenous opioid regulation of the hypothalamic-pituitary-adrenal axis in fetal sheep.
Brooks AN; Challis JR
J Endocrinol; 1988 Dec; 119(3):389-95. PubMed ID: 2851636
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of vasopressin release in man by an opiate peptide.
Grossman A; Besser GM; Milles JJ; Baylis PH
Lancet; 1980 Nov; 2(8204):1108-10. PubMed ID: 6107725
[TBL] [Abstract][Full Text] [Related]
9. Effects of naloxone and an enkephalin analog on serum prolactin, cortisol, and gonadotropins in the chimpanzee.
Gosselin RE; Blankstein J; Dent DW; Hobson WC; Fuller GB; Reyes FI; Winter JS; Faiman C
Endocrinology; 1983 Jun; 112(6):2168-73. PubMed ID: 6406210
[TBL] [Abstract][Full Text] [Related]
10. The effects of a met-enkephalin analogue on ACTH, beta-LPH, beta-endorphin and MET-enkephalin in patients with adrenocortical disease.
Gaillard RC; Grossman A; Smith R; Rees LH; Besser GM
Clin Endocrinol (Oxf); 1981 May; 14(5):471-8. PubMed ID: 6273021
[TBL] [Abstract][Full Text] [Related]
11. Effects of a Met-enkephalin analogue and naloxone infusion on anterior pituitary hormone secretion in acromegaly.
Delitala G; Giusti M; Borsi L; Devilla L; Mazzochi G; Lotti G; Giordano G
Horm Res; 1981; 15(2):88-98. PubMed ID: 6276286
[TBL] [Abstract][Full Text] [Related]
12. Hyperactivity of the hypothalamo-pituitary-adrenal axis in obesity: a study of ACTH, AVP, beta-lipotrophin and cortisol responses to insulin-induced hypoglycaemia.
Weaver JU; Kopelman PG; McLoughlin L; Forsling ML; Grossman A
Clin Endocrinol (Oxf); 1993 Sep; 39(3):345-50. PubMed ID: 8222297
[TBL] [Abstract][Full Text] [Related]
13. Effects of a met-enkephalin analog on adrenocorticotropin (ACTH), growth hormone, and prolactin in patients with ACTH hypersecretion.
Allolio B; Winkelmann W; Hipp FX; Kaulen D; Mies R
J Clin Endocrinol Metab; 1982 Jul; 55(1):1-7. PubMed ID: 6281297
[TBL] [Abstract][Full Text] [Related]
14. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
Inder WJ; Joyce PR; Ellis MJ; Evans MJ; Livesey JH; Donald RA
Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596
[TBL] [Abstract][Full Text] [Related]
15. The effect of a met-enkephalin analogue on growth hormone, prolactin, gonadotropins, cortisol and thyroid stimulating hormone in healthy elderly men.
Giusti M; Delitala G; Marini G; Uggias B; Sessarego P; Besser GM; Grossman A; Giordano G
Acta Endocrinol (Copenh); 1992 Sep; 127(3):205-9. PubMed ID: 1414144
[TBL] [Abstract][Full Text] [Related]
16. Opiate receptor blockade and diurnal pituitary and adrenal hormone levels.
Leslie RD; Prescott RW; Kendall-Taylor P; Cook D; Weightman D; Ratcliffe J; Ingram MC
Horm Metab Res; 1985 Feb; 17(2):86-9. PubMed ID: 2985486
[TBL] [Abstract][Full Text] [Related]
17. Studies off the opiate control of prolactin, GH and TSH.
Grossman A; Stubbs WA; Gaillard RC; Delitala G; Rees LH; Besser GM
Clin Endocrinol (Oxf); 1981 Apr; 14(4):381-6. PubMed ID: 7021012
[TBL] [Abstract][Full Text] [Related]
18. Evidence for the participation of endogenous opioids in the sympathoadrenal response to hypoglycaemia in man.
Bouloux PM; Grossman A; Lytras N; Besser GM
Clin Endocrinol (Oxf); 1985 Jan; 22(1):49-56. PubMed ID: 3884188
[TBL] [Abstract][Full Text] [Related]
19. Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: effect of naloxone.
Lanzone A; Guido M; Ciampelli M; Fulghesu AM; Pavone V; Proto C; Caruso A; Mancuso S
Clin Endocrinol (Oxf); 1996 Jul; 45(1):73-7. PubMed ID: 8796141
[TBL] [Abstract][Full Text] [Related]
20. Endogenous opioids and baroreflex control in humans.
Rubin PC; McLean K; Reid JL
Hypertension; 1983; 5(4):535-8. PubMed ID: 6862578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
